Cautious optimism about the use of a new anti-amyloid fibril antibody for the treatment of early-stage Alzheimer’s.
Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment
Cautious optimism about the use of a new anti-amyloid fibril antibody for the treatment of early-stage Alzheimer’s.